Trump recently proposed tariffs on pharmaceutical products. Experts say this could lead to added costs, drug shortages and even a stall in research and development.

The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

Without a carve-out for tariff exceptions for pharmaceuticals, prices will skyrocket for US patients, experts warn.

Analytical laboratory testing plays a pivotal role in every stage of drug development and manufacturing. From route design and optimization to clinical trials and ultimately the finished product, ...

Terahertz (THz) technology, utilizing waves located between the microwave and infrared regions of the electromagnetic spectrum, is gaining recognition for its unique ability to penetrate biological ...

Delay in MMJ Biopharma Cultivation's Application Sparks Calls for DEA Accountability and Reform "This isn't just a case of bureaucratic red tape or administrative lag-this appears ...

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...